AÂ lab openned in India on Thursday at theÂ Ahmedabad Civil Hospital that will reduce test timesÂ for drug-resistant strains of tuberculosisÂ and offer tests for free, Indian Express reports. At the new lab, test results can be given within 24 hours, which could reduce TB mortality, Indian Express writes. The new lab is…
The number of H1N1 (swine) flu cases are steadily declining in the Southern Hemisphere as the region’s flu season comes to an end, the WHO said Friday, the Associated Press reports.
The WHO’s flu chief Keiji Fukuda on Saturday called upon wealthy nations and vaccine manufacturers to donate H1N1 (swine) flu vaccines to developing countries, the Associated Press reports.
Recent Releases: Limiting Corruption; Mental Health; U.S. Global Health Policies; Non-Physician Administered ARV; African Health Ministers
Lancet Infectious Diseases Features ReflectionÂ On Use OfÂ HIV/AIDS Money In Mozambique A Lancet Infectious Diseases Reflection and Reaction piece says while PEPFAR’s “investment of over US$228 million into Mozambique in 2008 alone” resulted in “an exponential increase in the number of people on” ARVs andÂ boosted prevention programs, “[t]here is more money…
In the coming months, countries should prepare for an “explosion” in new cases of H1N1 (swine) flu until peak transmission of the virus is reached, the WHO’s Western Pacific director, Shin Young-soo told a symposium of health officials gathered in Beijing Friday, the Associated Press reports.
According to the latest WHO report out Wednesday, the number of confirmed H1N1 (swine) flu deaths since its emergence in April has reached 1,799 â€“ a jump from 1,462 deaths since the agency’s last update, Agence France-Presse/the Australian reports.
Also In Global Health News: Boosting Artemisinin Production; TB In Pakistan; Gambia Vaccine Initiative; HIV In Burkina Faso Children
Researchers Use Breeding Method To Create Plant With High Levels Of Artemisinin In an effort to produce more artemisinin than is naturally found in the plant artemisia annua, researchers at York University’s Centre for Novel Agricultural Products are using “fast-track breeding methods to create a plant that contains much higher…
HHS announced on Monday that manufacturing and packaging issues have reduced by more than half the number of H1N1 vaccine doses that will be available in October when the U.S. vaccination campaign is set to start, Reuters reports.
Also In Global Health News: NTD Consortium; Clean Water Access; PEPFAR Lab Donation; River Blindness Elimination; Vaccines In India
European Laboratories Form Consortium To Study Neglected Tropical Diseases A handful of European universities and industries have formed a consortium to “boost drug development for the treatment of two deadly diseases, the African sleeping sickness and Leishmaniasis, which affect millions of people worldwide,” afrol News reports. “This new project combines…
GlaxoSmithKline Begins Testing H1N1 Vaccine; Opinion Piece Addresses U.S. Role In Helping Developing Countries Procure Vaccine
“GlaxoSmithKline has started testing its pandemic H1N1 swine flu vaccine in humans, and expects to start giving the results to government agencies next month, the drug maker said on Friday,” Reuters reports.